Snowden Capital Advisors LLC Uro Gen Pharma Ltd. Transaction History

Snowden Capital Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Jan 08, 2024	SELL	$13.68 - $34.6 $171,000 - $432,500	-12,500 Closed	0 $0
Q3 2019 Jan 08, 2024	SELL	$23.83 - $36.44 $910,305 - $1.39 Million	-38,200 Reduced 75.35%	12,500 $2.98 Million
Q2 2019 Jan 08, 2024	BUY	$32.75 - $40.35 $1.66 Million - $2.05 Million	50,700 New	50,700 $4.5 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $251M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.